Skip to main content

Table 2 Number and percentages of patients with RRT and AKI according to outcome and targeted temperature management

From: Acute kidney injury and mild therapeutic hypothermia in patients after cardiopulmonary resuscitation - a post hoc analysis of a prospective observational trial

A

All patients (n = 126)

Normothermia (n = 71)

Hypothermia (n = 55)

p value

AKI, n (%)

49 (69)

24 (44)

0.004

 AKI 1, n (%)

21 (30)

11 (20)

 

 AKI 2, n (%)

8 (11)

4 (7)

 AKI 3, n (%)

20 (28)

9 (16)

RRT, n (%)

14 (20)

6 (11)

ns

B

Favourable outcome (n = 62)

Normothermia (n = 27)

Hypothermia (n = 35)

p value

AKI, n (%)

14 (52)

14 (40)

ns

 AKI 1, n (%)

5 (19)

8 (23)

 

 AKI 2, n (%)

2 (7)

3 (9)

 AKI 3, n (%)

7 (26)

3 (9)

RRT, n (%)

5 (19)

2 (6)

ns

C

Poor outcome (n = 64)

Normothermia (n = 44)

Hypothermia (n = 20)

p value

AKI, n (%)

35 (80)

10 (50)

0.017

 AKI 1, n (%)

16 (36)

3 (15)

 

 AKI 2, n (%)

6 (14)

1 (5)

 AKI 3, n (%)

13 (30)

6 (30)

RRT, n (%)

9 (21)

4 (20)

ns

  1. Number (and percentages) of patients with continuous renal replacement therapy (RRT) and Acute kidney injury (AKI) stage 1–3 and only stage 3 (Kidney Disease Improving Global Outcomes (KDIGO)) in all patients (A), patients with good (B) and poor (C) neurological outcome treated with mild therapeutic hypothermia or normothermia
  2. ns not significant